Nakamura Kazuyoshi, Habano Wataru, Kojo Toshiyuki, Komagiri You, Kubota Takahiro, Kubokawa Manabu
Department of Physiology II, Iwate Medical University School of Medicine, Morioka 020-8505, Japan.
J Physiol Sci. 2006 Dec;56(6):407-13. doi: 10.2170/physiolsci.RP003106. Epub 2006 Oct 26.
Nitric oxide (NO) modulates the activity of an inwardly rectifying K(+) channel in cultured human proximal tubule cells. In this study, we investigated which NO synthase (NOS) isoform(s) was involved in the endogenous production of NO and hence the regulation of channel activity. The patch-clamp experiments using the cell-attached mode showed that a nonselective NOS inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME; 100 microM), suppressed channel activity, whereas a NOS substrate, L-arginine (500 microM), stimulated it. A neuronal NOS (nNOS)/inducible NOS (iNOS)-selective inhibitor, 1-(alpha,alpha,alpha-trifluoro-o-tolyl)-imidazole (TRIM; 100 microM), suppressed channel activity to the same extent as L-NAME. TRIM also blocked the stimulatory effect of L-arginine. In contrast, an NO donor, sodium nitroprusside (10 microM) or 8-bromoguanosine 3',5'-cyclic monophosphate (100 microM) stimulated channel activity even in the presence of TRIM. RT-PCR revealed that iNOS mRNA alone was expressed in most of the cultures, i.e., 34 out of 40. In the other 6 cases, endothelial NOS (eNOS) and iNOS mRNA were simultaneously expressed. This finding was confirmed at the protein level by Western blotting. Indeed, in the patch-clamp experiments TRIM sometimes failed to suppress the channel activity, but the following addition of L-NAME suppressed it. However, since the suppressive effect of TRIM was usually similar to that of L-NAME, the involvement of eNOS in K(+) channel regulation would be relatively low. These results suggest that iNOS plays a pivotal role in the endogenous production of NO under the basal condition, which is involved in the activity of the inwardly rectifying K(+) channel in cultured human proximal tubule cells.
一氧化氮(NO)可调节培养的人近端小管细胞中内向整流钾通道的活性。在本研究中,我们调查了哪种一氧化氮合酶(NOS)同工型参与了内源性NO的产生,从而参与了通道活性的调节。采用细胞贴附模式的膜片钳实验表明,一种非选择性NOS抑制剂,N(ω)-硝基-L-精氨酸甲酯(L-NAME;100μM),可抑制通道活性,而一种NOS底物,L-精氨酸(500μM),则可刺激通道活性。一种神经元型NOS(nNOS)/诱导型NOS(iNOS)选择性抑制剂,1-(α,α,α-三氟邻甲苯基)-咪唑(TRIM;100μM),对通道活性的抑制程度与L-NAME相同。TRIM也阻断了L-精氨酸的刺激作用。相比之下,一种NO供体,硝普钠(10μM)或8-溴鸟苷3',5'-环一磷酸(100μM),即使在存在TRIM的情况下也能刺激通道活性。逆转录-聚合酶链反应(RT-PCR)显示,大多数培养物(即40个中的34个)中仅表达iNOS mRNA。在其他6个病例中,内皮型NOS(eNOS)和iNOS mRNA同时表达。这一发现通过蛋白质印迹在蛋白质水平上得到了证实。实际上,在膜片钳实验中,TRIM有时未能抑制通道活性,但随后加入L-NAME可抑制其活性。然而,由于TRIM的抑制作用通常与L-NAME相似,eNOS参与钾通道调节的程度相对较低。这些结果表明,iNOS在基础条件下内源性NO的产生中起关键作用,这与培养的人近端小管细胞中内向整流钾通道的活性有关。